Somatostatin and SMS 201-995 reverse the impairment of cognitive functions induced by cysteamine depletion of brain somatostatin

This publication has 27 references indexed in Scilit:

• Patients with Alzheimer's disease show an increased content of 15Kdalton somatostatin precursor and a lowered
  Life Sciences, 1986
• The Somatostatin Analog SMS 201-995 Induces Long-Acting Inhibition of Growth Hormone Secretion without Rebound Hypersecretion in Acromegalic Patients*
  Journal of Clinical Endocrinology & Metabolism, 1985
• Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients
  Nature, 1985
• Neuropeptides in aging and dementia
  Peptides, 1984
• Effects of cysteamine on pro-somatostatin related peptides
  Regulatory Peptides, 1983
• Biological effects of cysteamine: relationship to somatostatin depletion
  Regulatory Peptides, 1983
• Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents
  Psychopharmacology, 1982
• SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
  Life Sciences, 1982
• Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa
  Nature, 1980
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976